C9Orf72 gene modulator (Intravacc/DZNE)

N/A

Report date: 2025/03/14 16:37:27

Base Information

Drug NameC9Orf72 gene modulator (Intravacc/DZNE)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionGuanine nucleotide exchange C9orf72 modulators
TargetsGuanine nucleotide exchange C9orf72
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIntravacc BV
China Registration ClassN/A

Develop Information

Active CompaniesDeutsches Zentrum für Neurodegenerative Erkrankungen eVIntravacc BV
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A